Sfoglia per Autore
Reply to P.-H. Luo et al
2024 Monk, B; Colombo, N; Tewari, K; Tekin, C; Keefe, S; Lorusso, D
Letter to the editor-The new FIGO staging system for endometrial cancer: Is the paradigm shift clinically feasible?
2024 Betella, I; De Vitis, L; Calidona, C; Multinu, F; Colombo, N
Pembrolizumab or Placebo Plus Chemotherapy With or Without Bevacizumab for Persistent, Recurrent, or Metastatic Cervical Cancer: Subgroup Analyses From the KEYNOTE-826 Randomized Clinical Trial
2024 Tewari, K; Colombo, N; Monk, B; Dubot, C; Caceres, M; Hasegawa, K; Shapira-Frommer, R; Salman, P; Yanez, E; Gumus, M; de Mendoza, M; Samouelian, V; Castonguay, V; Arkhipov, A; Tekin, C; Li, K; Toker, S; Keefe, S; Lorusso, D
Photocatalytic Radical Coupling of Organoborates with α-Halogenated Electron-Poor Olefins
2024 Caldarelli, M; Rezzi, S; Colombo, N; Pirali, T; Papeo, G
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
2024 Oaknin, A; Gladieff, L; Martínez-García, J; Villacampa, G; Takekuma, M; De Giorgi, U; Lindemann, K; Woelber, L; Colombo, N; Duska, L; Leary, A; Godoy-Ortiz, A; Nishio, S; Angelergues, A; Rubio, M; Fariñas-Madrid, L; Yamaguchi, S; Lorusso, D; Ray-Coquard, I; Manso, L; Joly, F; Alarcón, J; Follana, P; Romero, I; Lebreton, C; Pérez-Fidalgo, J; Yunokawa, M; Dahlstrand, H; D'Hondt, V; Randall, L
Characterization and Management of Adverse Reactions in Patients With Advanced Endometrial Cancer Receiving Lenvatinib Plus Pembrolizumab
2024 Colombo, N; Lorusso, D; Monk, B; Slomovitz, B; Hasegawa, K; Nogueira-Rodrigues, A; Zale, M; Okpara, C; Barresi, G; Mckenzie, J; Makker, V
Early CAR- CD4+ T-lymphocytes recovery following CAR-T cell infusion: A worse outcome in diffuse large B cell lymphoma
2024 Gambella, M; Carlomagno, S; Mangerini, R; Colombo, N; Parodi, A; Ghiggi, C; Giannoni, L; Coviello, E; Setti, C; Luchetti, S; Serio, A; Laudisi, A; Passannante, M; Bo, A; Tedone, E; Sivori, S; Angelucci, E; Raiola, A
Clinical evaluation of a low-coverage whole-genome test for detecting homologous recombination deficiency in ovarian cancer
2024 Boidot, R; Blum, M; Wissler, M; Gottin, C; Ruzicka, J; Chevrier, S; Delhomme, T; Audoux, J; Jeanniard, A; Just, P; Harter, P; Pignata, S; Gonzalez-Martin, A; Marth, C; Maenpaa, J; Colombo, N; Vergote, I; Fujiwara, K; Duforet-Frebourg, N; Bertrand, D; Philippe, N; Ray-Coquard, I; Pujade-Lauraine, E
Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial
2023 Pujade-Lauraine, E; Brown, J; Barnicle, A; Wessen, J; Lao-Sirieix, P; Criscione, S; du Bois, A; Lorusso, D; Romero, I; Petru, E; Yoshida, H; Vergote, I; Colombo, N; Hietanen, S; Provansal, M; Schmalfeldt, B; Pignata, S; Martín Lorente, C; Berton, D; Runnebaum, I; Ray-Coquard, I
Multimodal treatment for resectable neuroendocrine carcinoma of the cervix
2023 Valenza, C; Spada, F; Multinu, F; Benini, L; Borghesani, M; Algeri, L; Rubino, M; Pisa, E; Gervaso, L; Cella, C; Carinelli, S; Bruni, S; Schivardi, G; Curigliano, G; Zanagnolo, V; Aletti, G; Colombo, N; Fazio, N
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial
2023 Pignata, S; Scambia, G; Schettino, C; Arenare, L; Pisano, C; Lombardi, D; De Giorgi, U; Andreetta, C; Cinieri, S; De Angelis, C; Priolo, D; Casanova, C; Rosati, M; Greco, F; Zafarana, E; Schiavetto, I; Mammoliti, S; Cecere, S; Salutari, V; Scalone, S; Farolfi, A; Di Napoli, M; Lorusso, D; Gargiulo, P; Califano, D; Russo, D; Spina, A; De Cecio, R; Chiodini, P; Perrone, F; Accinno, V; Altavilla, C; Antonelli, G; Artioli, G; Avola, F; Barbara, B; Barbato, V; Bartoletti, M; Bevilacqua, S; Bordonaro, R; Borghese, O; Buonfanti, G; Camarda, F; Canzanella, G; Carbone, V; Carbone, M; Carlo Stella, G; Cassani, C; Castagna, F; Cattaneo, M; Cinefra, M; Colombo, N; Corsetti, S; Dall'Agata, M; D'Amico, M; Daniele, G; De Marino, E; De Matteis, G; De Placido, S; Del Bene, G; Del Giudice, A; Del Monte, F; Del Sesto, M; Donini, M; Drudi, G; Falcone, G; Favaretto, A; Ferrera, G; Florio, M; Forestieri, V; Gallo, M; Gallo, C; Garibaldi, F; Gerevini, F; Ghizzoni, V; Giganti, M; Gimigliano, A; Giudice, E; Gnocchi, N; Gravina, A; Greggi, S; Iaia, M; Ilardi, A; Iovine, G; Ippoliti, G; Irollo, G; Isidori, I; Lapresa, M; Lavenia, G; Longhitano, L; Lucia, B; Luzi, G; Mariano, S; Marino, V; Marrapese, G; Martino, M; Matocci, R; Mazzoni, E; Mercuri, D; Mirto, M
Reply to Z.R. McCaw et al
2023 Matulonis, U; Lorusso, D; Oaknin, A; Pignata, S; Dean, A; Denys, H; Colombo, N; Van Gorp, T; Konner, J; Marin, M; Harter, P; Murphy, C; Wang, J; Noble, E; Esteves, B; Method, M; Coleman, R
Lenvatinib Plus Pembrolizumab in Previously Treated Advanced Endometrial Cancer: Updated Efficacy and Safety From the Randomized Phase III Study 309/KEYNOTE-775
2023 Makker, V; Colombo, N; Herráez, A; Monk, B; Mackay, H; Santin, A; Miller, D; Moore, R; Baron-Hay, S; Ray-Coquard, I; Ushijima, K; Yonemori, K; Kim, Y; Guerra Alia, E; Sanli, U; Bird, S; Orlowski, R; Mckenzie, J; Okpara, C; Barresi, G; Lorusso, D
Adult ovarian granulosa cell tumors: analysis of outcomes and risk factors for recurrence
2023 Plett, H; Ricciardi, E; Vacaru, V; Ramspott, J; Colombo, N; Sehouli, J; du Bois, A; Garbi, A; Richter, R; Ataseven, B; Aletti, G; Braicu, E; Heitz, F; Portuesi, R; Muallem, M; Dagres, T; Parma, G; Roser, E; Traut, A; Multinu, F; Harter, P
Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline ☆
2023 Sessa, C; Balmana, J; Bober, S; Cardoso, M; Colombo, N; Curigliano, G; Domchek, S; Evans, D; Fischerova, D; Harbeck, N; Kuhl, C; Lemley, B; Levy-Lahad, E; Lambertini, M; Ledermann, J; Loibl, S; Phillips, K; Paluch-Shimon, S
Hydrological, thermal and chemical influence of an intact rock glacier discharge on mountain stream water
2023 Bearzot, F; Colombo, N; Cremonese, E; di Cella, U; Drigo, E; Caschetto, M; Basiricò, S; Crosta, G; Frattini, P; Freppaz, M; Pogliotti, P; Salerno, F; Brunier, A; Rossini, M
Randomized Phase III Study Comparing Neoadjuvant Chemotherapy Followed by Surgery Versus Chemoradiation in Stage IB2-IIB Cervical Cancer: EORTC-55994
2023 Kenter, G; Greggi, S; Vergote, I; Katsaros, D; Kobierski, J; van Doorn, H; Landoni, F; van der Velden, J; Reed, N; Coens, C; van Luijk, I; Colombo, N; Steen-Banasik, E; Ottevanger, N; Casado, A
Health-related quality of life with pembrolizumab or placebo plus chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer (KEYNOTE-826): a randomised, double-blind, placebo-controlled, phase 3 trial
2023 Monk, B; Tewari, K; Dubot, C; Caceres, M; Hasegawa, K; Shapira-Frommer, R; Salman, P; Yañez, E; Gümüş, M; Hurtado de Mendoza, M; Samouëlian, V; Castonguay, V; Arkhipov, A; Tekin, C; Li, K; Martin Nguyen, A; Monberg, M; Colombo, N; Lorusso, D
Endometrial carcinosarcoma
2023 Bogani, G; Ray-Coquard, I; Concin, N; Ngoi, N; Morice, P; Caruso, G; Enomoto, T; Takehara, K; Denys, H; Lorusso, D; Coleman, R; Vaughan, M; Takano, M; Provencher, D; Sagae, S; Wimberger, P; Póka, R; Segev, Y; Kim, S; Kim, J; Candido Dos Reis, F; Ramirez, P; Mariani, A; Leitao, M; Makker, V; Abu-Rustum, N; Vergote, I; Zannoni, G; Tan, D; Mccormack, M; Paolini, B; Bini, M; Raspagliesi, F; Benedetti Panici, P; Di Donato, V; Muzii, L; Colombo, N; Pignata, S; Scambia, G; Monk, B
Poly (ADP-ribose) polymerase inhibitors (PARPi) in ovarian cancer: lessons learned and future directions
2023 Caruso, G; Tomao, F; Parma, G; Lapresa, M; Multinu, F; Palaia, I; Aletti, G; Colombo, N
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile